Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 01, 2022
Antiverse announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in identifying antibody candidates for a target of interest, with ...
read more
Tuesday, February 01, 2022
Elusys Therapeutics has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax ...
read more
Tuesday, February 01, 2022
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Kevin Lundquist as Chief Financial Officer, effective January 31, 2022...
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, ...
read more
Ablexis, LLC and AlivaMab Discovery Services, LLC announced a multi-target licensing agreement between Ablexis and Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, and a research partnership between ADS and Almirall.
read more
After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development. Formulation development for ATMPs, including cell culture ...
read more
Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
read more
Inotiv, Inc. announced that the company has completed the purchase of Orient BioResource Center, Inc. (“OBRC”), from Orient Bio, Inc., a preclinical contract research organization and animal model supplier based in Seongnam, South Korea. Orient ...
read more
Alcami announced a $10 million investment to expand its laboratory operation in Durham, North Carolina. The investment adds over 6700 ft² to the existing laboratory footprint, new equipment, and capabilities to enhance drug substance and drug product...
read more
Thursday, January 27, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation under which Fujifilm will acquire Atara’s T-Cell Operations and Manufacturing (ATOM) ...
read more
Thursday, January 27, 2022
Charles River Laboratories International, Inc. has announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles ...
read more
Wednesday, January 26, 2022
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US ...
read more
Wednesday, January 26, 2022
Aceto has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, ...
read more
Tuesday, January 25, 2022
Sharp has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.
read more
Tuesday, January 25, 2022
The project will include the construction of five new laboratories: two of which will be dedicated to research and development; a scale-up chemical synthesis laboratory; as well as Quality Control and analytical services laboratories. All work is due...
read more